• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter Telegram
Iranian Journal of Pharmaceutical Research
Articles in Press
Current Issue
Journal Archive
Volume Volume 18 (2019)
Volume Volume 17 (2018)
Volume Volume 16 (2017)
Volume Volume 15 (2016)
Volume Volume 14 (2015)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue supplement
Issue Issue 1
Volume Volume 13 (2014)
Volume Volume 12 (2013)
Volume Volume 11 (2012)
Volume Volume 10 (2011)
Volume Volume 9 (2010)
Volume Volume 8 (2009)
Volume Volume 7 (2008)
Volume Volume 6 (2007)
Volume Volume 5 (2006)
Volume Volume 4 (2005)
Volume Volume 3 (2004)
Volume Volume 2 (2003)
Volume Volume 1 (2002)
Mehralian, G., Bastani, P. (2015). Pharmaceutical Strategic Purchasing: a Key to Improve Access to Medicines. Iranian Journal of Pharmaceutical Research, 14(2), 345-346.
Gholamhossein Mehralian; Peivand Bastani. "Pharmaceutical Strategic Purchasing: a Key to Improve Access to Medicines". Iranian Journal of Pharmaceutical Research, 14, 2, 2015, 345-346.
Mehralian, G., Bastani, P. (2015). 'Pharmaceutical Strategic Purchasing: a Key to Improve Access to Medicines', Iranian Journal of Pharmaceutical Research, 14(2), pp. 345-346.
Mehralian, G., Bastani, P. Pharmaceutical Strategic Purchasing: a Key to Improve Access to Medicines. Iranian Journal of Pharmaceutical Research, 2015; 14(2): 345-346.

Pharmaceutical Strategic Purchasing: a Key to Improve Access to Medicines

Editorial, Volume 14, Issue 2, Spring 2015, Page 345-346  XML PDF (264 K)
Authors
Gholamhossein Mehralian ; Peivand Bastani
Department of Pharmacoeconomic and Pharma management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract
 
 
Pharmaceuticals are often considered as the most significant cost driver of health care expenditures and at the same time have a major impact on patients’ curative processes and outcomes. Other pieces of evidence emphasize that drugs are the input for the production of good health. They are considered as the most important and expensive element in the healthy supply chain and are more associated with the management and economics rather than other factors. So, the availability of the relevant, effective, and payable drugs at the time of need and their rapid diffusion at affordable prices are important indicators of the utilization of health services. They can be considered as the most visible determinant of quality and the major driver source of the phenomenal increase in longevity of the human race over the past decades.
 
Statistics
Article View: 4,810
PDF Download: 9,275
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Statistics

Journal Management System. Designed by sinaweb.